Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 1.00 |
| ▸ | HTT | P42858 | 2/20 | 0.69 |
| ▸ | LPAR5 | Q9H1C0 | 4/20 | 0.59 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | LPAR1 | Q92633 | 4/20 | 0.46 |
| ▸ | LPAR2 | Q9HBW0 | 4/20 | 0.46 |
| ▸ | LPAR3 | Q9UBY5 | 4/20 | 0.46 |
| ▸ | LPAR6 | P43657 | 3/20 | 0.46 |
| ▸ | LPAR4 | Q99677 | 3/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1965457 | 1.00 | USP2 (1.00) | USP2HTTLPAR5PLA2G2CMEN1 | |
| SCHEMBL9248716 | 1.00 | USP2 (1.00) | USP2HTTLPAR5PLA2G2CMEN1 | |
| SCHEMBL8022797 | 1.00 | USP2 (1.00) | USP2HTTLPAR5PLA2G2CMEN1 | |
| SCHEMBL116830 | 1.00 | USP2 (1.00) | USP2HTTLPAR5PLA2G2CMEN1 | |
| SCHEMBL8856104 | 1.00 | USP2 (1.00) | USP2HTTLPAR5PLA2G2CMEN1 | |
| SCHEMBL24835077 | 1.00 | USP2 (1.00) | USP2HTTLPAR5PLA2G2CMEN1 | |
| SCHEMBL932977 | 1.00 | USP2 (1.00) | USP2HTTLPAR5PLA2G2CMEN1 | |
| SCHEMBL1086330 | 1.00 | USP2 (1.00) | USP2HTTLPAR5PLA2G2CMEN1 | |
| SCHEMBL21082980 | 1.00 | USP2 (1.00) | USP2HTTLPAR5PLA2G2CMEN1 | |
| SCHEMBL38241 | 1.00 | USP2 (1.00) | USP2HTTLPAR5PLA2G2CMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12090205-B2 | Poloxamer compositions with reduced sol-gel transition temperatures and methods of reducing the sol-gel transition temperature of poloxamer compositions | ROCHAL TECHNOLOGIES LLC (US) | 2024-09-17 | — | — | US | claimed |
| CN-116829203-A | Coated medical product | 亨莫特克股份公司 | 2023-09-29 | — | — | CN | claimed |
| CN-116710156-A | Coated medical product | 亨莫特克股份公司 | 2023-09-05 | — | — | CN | claimed |
| EP-3204037-B1 | COMPOSITIONS AND KITS FOR ENZYMATIC DEBRIDEMENT AND METHODS OF USING THE SAME | ROCHAL TECH LLC (US) | 2022-12-07 | — | — | EP | claimed |
| CN-107106663-B | Compositions and kits for enzymatic debridement and methods of use thereof | 罗查尔科技有限责任公司 | 2022-12-06 | — | — | CN | claimed |
| EP-4051239-A1 | POLOXAMER COMPOSITIONS WITH REDUCED SOL-GEL TRANSITION TEMPERATURES AND METHODS OF REDUCING THE SOL-GEL TRANSITION TEMPERATURE OF POLOXAMER COMPOSITIONS | Rochal Technologies LLC (US) | 2022-09-07 | — | — | EP | claimed |
| CN-114929200-A | Method for lowering sol-gel transition temperature | 罗查尔科技有限责任公司 | 2022-08-19 | — | — | CN | claimed |
| WO-2021086698-A1 | METHODS FOR REDUCING THE TEMPERATURE OF SOL-GEL TRANSITIONS | ROCHAL INDUSTRIES, LLC (US) | 2021-05-06 | — | — | WO | claimed |
| US-20210121575-A1 | Poloxamer Compositions With Reduced Sol-Gel Transition Temperatures and Methods of Reducing the Sol-Gel Transition Temperature of Poloxamer Compositions | ROCHAL INDUSTRIES, LLC (US) | 2021-04-29 | — | — | US | claimed |
| EP-2787985-B1 | BIOCIDAL COMPOSITIONS AND METHODS OF USING THE SAME | ROCHAL IND LLC (US) | 2020-07-01 | — | — | EP | claimed |
| CN-107106663-A | Composition and kit and its application method for enzyme debridement | 罗查尔工业有限责任公司 | 2017-08-29 | — | — | CN | claimed |
| EP-3204037-A1 | COMPOSITIONS AND KITS FOR ENZYMATIC DEBRIDEMENT AND METHODS OF USING THE SAME | Rochal Industries, LLC (US) | 2017-08-16 | — | — | EP | claimed |
| US-20170151314-A1 | COMPOSITIONS AND KITS FOR ENZYMATIC DEBRIDEMENT AND METHODS OF USING THE SAME | CRG SERVICING LLC | 2017-06-01 | — | — | US | claimed |
| US-9592280-B2 | Compositions and kits for enzymatic debridement and methods of using the same | ROCHAL INDUSTRIES LLC (US) | 2017-03-14 | — | — | US | claimed |
| US-20160199459-A1 | COMPOSITIONS AND KITS FOR TREATING PRURITUS AND METHODS OF USING THE SAME | CRG SERVICING LLC | 2016-07-14 | — | — | US | claimed |
| WO-2016057788-A1 | COMPOSITIONS AND KITS FOR ENZYMATIC DEBRIDEMENT AND METHODS OF USING THE SAME | ROCHAL INDUSTRIES, LLC (US) | 2016-04-14 | — | — | WO | claimed |
| US-20160101165-A1 | COMPOSITIONS AND KITS FOR ENZYMATIC DEBRIDEMENT AND METHODS OF USING THE SAME | CRG SERVICING LLC | 2016-04-14 | — | — | US | claimed |
| US-20160101166-A1 | COMPOSITIONS AND KITS FOR TREATING PRURITUS AND METHODS OF USING THE SAME | CRG SERVICING LLC | 2016-04-14 | — | — | US | claimed |
| US-8829053-B2 | Biocidal compositions and methods of using the same | ROCHAL INDUSTRIES LLP (US) | 2014-09-09 | — | — | US | claimed |
| US-20130150451-A1 | BIOCIDAL COMPOSITIONS AND METHODS OF USING THE SAME | ROCHAL INDUSTRIES, LLP (US) | 2013-06-13 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12090205-B2 | Poloxamer compositions with reduced sol-gel transition temperatures and methods of reducing the sol-gel transition temperature of poloxamer compositions | PAOX, HPGDS, SPTSSB | USP2 706/4885HTT 2356/4885LPAR5 1253/4885 |
| US-20210121575-A1 | Poloxamer Compositions With Reduced Sol-Gel Transition Temperatures and Methods of Reducing the Sol-Gel Transition Temperature of Poloxamer Compositions | PAOX, HPGDS, SPTSSB | USP2 706/4885HTT 2356/4885LPAR5 1253/4885 |
| US-20130150451-A1 | BIOCIDAL COMPOSITIONS AND METHODS OF USING THE SAME | GCG, BID, DGAT1 | USP2 1260/4885HTT 4280/4885LPAR5 3209/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.